Korsana Biosciences (KRSA) FCF Margin (2019 - 2025)
Korsana Biosciences (KRSA) reported FCF Margin of -30.17% for Q3 2025, up 854.36 percentage points from -884.54% a year earlier and up 510.69 percentage points from the prior quarter.
Powered by 
Analysis
Korsana Biosciences (KRSA) FCF Margin (2019 - 2025) Analysis & Trends
Over the twelve months ended Sep 30, 2025, Korsana Biosciences' FCF Margin came in at -48.16%, up 3165.24 percentage points year-over-year; for FY2024, it came in at -216.65%.
- FCF Margin has a five-year change of +2204.10 percentage points (FY2019 to FY2024).
- By year, FCF Margin came in at -13673.74% in FY2022 (-12747.20 pp), -926.53% in FY2021 (+2297.07 pp) and -3223.61% in FY2020 (-802.86 pp).
- Five-year quarterly FCF Margin spans a low of -23314.52% in Q1 2021 and a high of 19.93% in Q4 2024.
- The high point for year-over-year FCF Margin in five years was Q1 2022 (a gain of 21509.31 percentage points); the low point was Q1 2021 (a drop of 20298.24 percentage points).
- Per Business Quant data, the three quarters before Q3 2025 came in at -540.86% (Q2 2025), -1195.06% (Q1 2025) and 19.93% (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 43.05% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 34.72% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.01% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 30.39% |
| 10 | Korsana Biosciences | 16.27 Mn | 1.82 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -30.17% |
| Jun 30, 2025 | -540.86% |
| Mar 31, 2025 | -1,195.06% |
| Dec 31, 2024 | 19.93% |
| Sep 30, 2024 | -884.54% |
| Jun 30, 2022 | -3,535.29% |
| Mar 31, 2022 | -1,805.20% |
| Dec 31, 2021 | -1,619.14% |
| Sep 30, 2021 | -2,276.72% |
| Jun 30, 2021 | -183.63% |
| Mar 31, 2021 | -23,314.52% |
| Dec 31, 2020 | -10,583.46% |
| Sep 30, 2020 | -3,764.25% |
| Jun 30, 2020 | -1,908.68% |
| Mar 31, 2020 | -3,016.27% |
| Dec 31, 2019 | -1,508.24% |
| Sep 30, 2019 | -1,750.00% |
| Jun 30, 2019 | -1,610.32% |
API Access
Korsana Biosciences FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=KRSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "KRSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=KRSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();